What is the therapeutic window for peripheral immune modulation to prevent CNS damage?

immunology open composite 68%
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
68%
Novelty
70%
Mechanistic
—
Druggability
—
Priority
75%
Importance
90%
Tractability
75%
Market price
50%

Description

The debate raised peripheral immune targeting as promising but did not address timing considerations or reversibility of CNS changes. Determining when interventions remain effective is crucial for clinical translation and patient selection.

Source: Debate session sess_SDA-2026-04-04-frontier-immunomics-e6f97b29 (Analysis: SDA-2026-04-04-frontier-immunomics-e6f97b29)